 | • レポートコード：GIR-107A13987 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、細菌性膣炎治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細菌性膣炎治療薬の種類別市場規模（医療、外科、その他）、用途別市場規模（病院、クリニック、診断研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・細菌性膣炎治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Merck、Novartis、Lupin Pharmaceuticals、Symbiomix Therapeutics、Mission Pharmacal Company、Bayer、Sanofi、Starpharma Holdings、Alfa Wassermann、AmVac、Evofem、Osel ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：医療、外科、その他 ・用途別分析2016年-2026年：病院、クリニック、診断研究所、その他 ・細菌性膣炎治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・細菌性膣炎治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・細菌性膣炎治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・細菌性膣炎治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・細菌性膣炎治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bacterial Vaginosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bacterial Vaginosis Therapeutics size is estimated to be USD 1267.3 million in 2026 from USD 967.3 million in 2020, with a change XX% between 2020 and 2021. The global Bacterial Vaginosis Therapeutics market size is expected to grow at a CAGR of 7.0% for the next five years.
Market segmentation
Bacterial Vaginosis Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Medicine
Surgery
Other
Market segment by Application, can be divided into
Hospitals
Clinics
Diagnostic Laboratories
Other
Market segment by players, this report covers
Pfizer
Merck
Novartis
Lupin Pharmaceuticals
Symbiomix Therapeutics
Mission Pharmacal Company
Bayer
Sanofi
Starpharma Holdings
Alfa Wassermann
AmVac
Evofem
Osel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Bacterial Vaginosis Therapeutics
1.2 Classification of Bacterial Vaginosis Therapeutics by Type
1.2.1 Overview: Global Bacterial Vaginosis Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type in 2020
1.2.3 Medicine
1.2.4 Surgery
1.2.5 Other
1.3 Global Bacterial Vaginosis Therapeutics Market by Application
1.3.1 Overview: Global Bacterial Vaginosis Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Other
1.4 Global Bacterial Vaginosis Therapeutics Market Size & Forecast
1.5 Global Bacterial Vaginosis Therapeutics Market Size and Forecast by Region
1.5.1 Global Bacterial Vaginosis Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Bacterial Vaginosis Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Bacterial Vaginosis Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Bacterial Vaginosis Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Bacterial Vaginosis Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Bacterial Vaginosis Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacterial Vaginosis Therapeutics Market Drivers
1.6.2 Bacterial Vaginosis Therapeutics Market Restraints
1.6.3 Bacterial Vaginosis Therapeutics Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Bacterial Vaginosis Therapeutics Product and Solutions
2.1.4 Pfizer Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Bacterial Vaginosis Therapeutics Product and Solutions
2.2.4 Merck Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Bacterial Vaginosis Therapeutics Product and Solutions
2.3.4 Novartis Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Lupin Pharmaceuticals
2.4.1 Lupin Pharmaceuticals Details
2.4.2 Lupin Pharmaceuticals Major Business
2.4.3 Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Product and Solutions
2.4.4 Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.5 Symbiomix Therapeutics
2.5.1 Symbiomix Therapeutics Details
2.5.2 Symbiomix Therapeutics Major Business
2.5.3 Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Product and Solutions
2.5.4 Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Symbiomix Therapeutics Recent Developments and Future Plans
2.6 Mission Pharmacal Company
2.6.1 Mission Pharmacal Company Details
2.6.2 Mission Pharmacal Company Major Business
2.6.3 Mission Pharmacal Company Bacterial Vaginosis Therapeutics Product and Solutions
2.6.4 Mission Pharmacal Company Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Mission Pharmacal Company Recent Developments and Future Plans
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Bacterial Vaginosis Therapeutics Product and Solutions
2.7.4 Bayer Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bayer Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Bacterial Vaginosis Therapeutics Product and Solutions
2.8.4 Sanofi Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Starpharma Holdings
2.9.1 Starpharma Holdings Details
2.9.2 Starpharma Holdings Major Business
2.9.3 Starpharma Holdings Bacterial Vaginosis Therapeutics Product and Solutions
2.9.4 Starpharma Holdings Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Starpharma Holdings Recent Developments and Future Plans
2.10 Alfa Wassermann
2.10.1 Alfa Wassermann Details
2.10.2 Alfa Wassermann Major Business
2.10.3 Alfa Wassermann Bacterial Vaginosis Therapeutics Product and Solutions
2.10.4 Alfa Wassermann Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Alfa Wassermann Recent Developments and Future Plans
2.11 AmVac
2.11.1 AmVac Details
2.11.2 AmVac Major Business
2.11.3 AmVac Bacterial Vaginosis Therapeutics Product and Solutions
2.11.4 AmVac Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 AmVac Recent Developments and Future Plans
2.12 Evofem
2.12.1 Evofem Details
2.12.2 Evofem Major Business
2.12.3 Evofem Bacterial Vaginosis Therapeutics Product and Solutions
2.12.4 Evofem Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Evofem Recent Developments and Future Plans
2.13 Osel
2.13.1 Osel Details
2.13.2 Osel Major Business
2.13.3 Osel Bacterial Vaginosis Therapeutics Product and Solutions
2.13.4 Osel Bacterial Vaginosis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Osel Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Bacterial Vaginosis Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Bacterial Vaginosis Therapeutics Players Market Share
3.2.2 Top 10 Bacterial Vaginosis Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Bacterial Vaginosis Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Bacterial Vaginosis Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Bacterial Vaginosis Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Bacterial Vaginosis Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Bacterial Vaginosis Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Bacterial Vaginosis Therapeutics Revenue by Type (2016-2026)
6.2 North America Bacterial Vaginosis Therapeutics Revenue by Application (2016-2026)
6.3 North America Bacterial Vaginosis Therapeutics Market Size by Country
6.3.1 North America Bacterial Vaginosis Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Bacterial Vaginosis Therapeutics Revenue by Type (2016-2026)
7.2 Europe Bacterial Vaginosis Therapeutics Revenue by Application (2016-2026)
7.3 Europe Bacterial Vaginosis Therapeutics Market Size by Country
7.3.1 Europe Bacterial Vaginosis Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region
8.3.1 Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Region (2016-2026)
8.3.2 China Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Bacterial Vaginosis Therapeutics Revenue by Type (2016-2026)
9.2 South America Bacterial Vaginosis Therapeutics Revenue by Application (2016-2026)
9.3 South America Bacterial Vaginosis Therapeutics Market Size by Country
9.3.1 South America Bacterial Vaginosis Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country
10.3.1 Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Bacterial Vaginosis Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Bacterial Vaginosis Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Bacterial Vaginosis Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Bacterial Vaginosis Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Bacterial Vaginosis Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Bacterial Vaginosis Therapeutics Product and Solutions
Table 9. Pfizer Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Bacterial Vaginosis Therapeutics Product and Solutions
Table 13. Merck Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Bacterial Vaginosis Therapeutics Product and Solutions
Table 17. Novartis Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Lupin Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Lupin Pharmaceuticals Major Business
Table 20. Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Product and Solutions
Table 21. Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Symbiomix Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. Symbiomix Therapeutics Major Business
Table 24. Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Product and Solutions
Table 25. Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Mission Pharmacal Company Corporate Information, Head Office, and Major Competitors
Table 27. Mission Pharmacal Company Major Business
Table 28. Mission Pharmacal Company Bacterial Vaginosis Therapeutics Product and Solutions
Table 29. Mission Pharmacal Company Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bayer Corporate Information, Head Office, and Major Competitors
Table 31. Bayer Major Business
Table 32. Bayer Bacterial Vaginosis Therapeutics Product and Solutions
Table 33. Bayer Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Bacterial Vaginosis Therapeutics Product and Solutions
Table 37. Sanofi Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Starpharma Holdings Corporate Information, Head Office, and Major Competitors
Table 39. Starpharma Holdings Major Business
Table 40. Starpharma Holdings Bacterial Vaginosis Therapeutics Product and Solutions
Table 41. Starpharma Holdings Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Alfa Wassermann Corporate Information, Head Office, and Major Competitors
Table 43. Alfa Wassermann Major Business
Table 44. Alfa Wassermann Bacterial Vaginosis Therapeutics Product and Solutions
Table 45. Alfa Wassermann Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. AmVac Corporate Information, Head Office, and Major Competitors
Table 47. AmVac Major Business
Table 48. AmVac Bacterial Vaginosis Therapeutics Product and Solutions
Table 49. AmVac Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Evofem Corporate Information, Head Office, and Major Competitors
Table 51. Evofem Major Business
Table 52. Evofem Bacterial Vaginosis Therapeutics Product and Solutions
Table 53. Evofem Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Osel Corporate Information, Head Office, and Major Competitors
Table 55. Osel Major Business
Table 56. Osel Bacterial Vaginosis Therapeutics Product and Solutions
Table 57. Osel Bacterial Vaginosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Bacterial Vaginosis Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 59. Global Bacterial Vaginosis Therapeutics Revenue Share by Players (2019-2021)
Table 60. Breakdown of Bacterial Vaginosis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Bacterial Vaginosis Therapeutics Players Head Office, Products and Services Provided
Table 62. Bacterial Vaginosis Therapeutics Mergers & Acquisitions in the Past Five Years
Table 63. Bacterial Vaginosis Therapeutics New Entrants and Expansion Plans
Table 64. Global Bacterial Vaginosis Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 65. Global Bacterial Vaginosis Therapeutics Revenue Share by Type (2016-2021)
Table 66. Global Bacterial Vaginosis Therapeutics Revenue Forecast by Type (2021-2026)
Table 67. Global Bacterial Vaginosis Therapeutics Revenue by Application (2016-2021)
Table 68. Global Bacterial Vaginosis Therapeutics Revenue Forecast by Application (2021-2026)
Table 69. North America Bacterial Vaginosis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Bacterial Vaginosis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Bacterial Vaginosis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Bacterial Vaginosis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Bacterial Vaginosis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Bacterial Vaginosis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Bacterial Vaginosis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Bacterial Vaginosis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Bacterial Vaginosis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Bacterial Vaginosis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Bacterial Vaginosis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Bacterial Vaginosis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Bacterial Vaginosis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Bacterial Vaginosis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Bacterial Vaginosis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Bacterial Vaginosis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Bacterial Vaginosis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Bacterial Vaginosis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Bacterial Vaginosis Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Bacterial Vaginosis Therapeutics Picture
Figure 2. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type in 2020
Figure 3. Medicine
Figure 4. Surgery
Figure 5. Other
Figure 6. Bacterial Vaginosis Therapeutics Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Other Picture
Figure 11. Global Bacterial Vaginosis Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Bacterial Vaginosis Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Bacterial Vaginosis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Bacterial Vaginosis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Bacterial Vaginosis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Bacterial Vaginosis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Bacterial Vaginosis Therapeutics Market Drivers
Figure 21. Bacterial Vaginosis Therapeutics Market Restraints
Figure 22. Bacterial Vaginosis Therapeutics Market Trends
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Lupin Pharmaceuticals Recent Developments and Future Plans
Figure 27. Symbiomix Therapeutics Recent Developments and Future Plans
Figure 28. Mission Pharmacal Company Recent Developments and Future Plans
Figure 29. Bayer Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Starpharma Holdings Recent Developments and Future Plans
Figure 32. Alfa Wassermann Recent Developments and Future Plans
Figure 33. AmVac Recent Developments and Future Plans
Figure 34. Evofem Recent Developments and Future Plans
Figure 35. Osel Recent Developments and Future Plans
Figure 36. Global Bacterial Vaginosis Therapeutics Revenue Share by Players in 2020
Figure 37. Bacterial Vaginosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Bacterial Vaginosis Therapeutics Revenue Market Share in 2020
Figure 39. Global Top 10 Players Bacterial Vaginosis Therapeutics Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Bacterial Vaginosis Therapeutics Revenue Share by Type in 2020
Figure 42. Global Bacterial Vaginosis Therapeutics Market Share Forecast by Type (2021-2026)
Figure 43. Global Bacterial Vaginosis Therapeutics Revenue Share by Application in 2020
Figure 44. Global Bacterial Vaginosis Therapeutics Market Share Forecast by Application (2021-2026)
Figure 45. North America Bacterial Vaginosis Therapeutics Sales Market Share by Type (2016-2026)
Figure 46. North America Bacterial Vaginosis Therapeutics Sales Market Share by Application (2016-2026)
Figure 47. North America Bacterial Vaginosis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 48. United States Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Bacterial Vaginosis Therapeutics Sales Market Share by Type (2016-2026)
Figure 52. Europe Bacterial Vaginosis Therapeutics Sales Market Share by Application (2016-2026)
Figure 53. Europe Bacterial Vaginosis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 54. Germany Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Bacterial Vaginosis Therapeutics Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Bacterial Vaginosis Therapeutics Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Bacterial Vaginosis Therapeutics Revenue Market Share by Region (2016-2026)
Figure 62. China Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Bacterial Vaginosis Therapeutics Sales Market Share by Type (2016-2026)
Figure 69. South America Bacterial Vaginosis Therapeutics Sales Market Share by Application (2016-2026)
Figure 70. South America Bacterial Vaginosis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Bacterial Vaginosis Therapeutics Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Bacterial Vaginosis Therapeutics Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Bacterial Vaginosis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Bacterial Vaginosis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界のグラム陰性菌感染症治療市場 2021：企業別、地域別、種類・用途別 The Gram-Negative Bacterial Infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- 世界の細菌性眼感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Bacterial Eye Infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の膣炎治療薬市場 2021：企業別、地域別、種類・用途別 The Vaginosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の抗真菌＆抗菌塗料市場 2021：企業別、地域別、種類・用途別 The Anti-Fungal and Anti-Bacterial Paints market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の結膜炎治療薬市場 2021：企業別、地域別、種類・用途別 The Conjunctivitis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…